Belumosudil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications

Variability in belumosudil exposure due to coadministration of voriconazole and isavuconazole in a patient with chronic graft-versus-host disease: Case report.

Variability in belumosudil exposure due to coadministration of voriconazole and isavuconazole in a patient with chronic graft-versus-host disease: Case report.

Journal: International journal of clinical pharmacology and therapeutics
Published: August 05, 2026

Chronic graft-versus-host disease: Update on pathobiology, biomarkers, and evolving treatment algorithms.

Chronic graft-versus-host disease: Update on pathobiology, biomarkers, and evolving treatment algorithms.

Journal: Cell transplantation
Published: July 22, 2026

Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease.

Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease.

Journal: Transplantation and cellular therapy
Published: July 08, 2026

Adult Cutaneous Chronic Graft-Versus-Host Disease: An In-Depth Review.

Adult Cutaneous Chronic Graft-Versus-Host Disease: An In-Depth Review.

Journal: Journal of cutaneous medicine and surgery
Published: July 04, 2026

Belumosudil in patients with bronchiolitis obliterans syndrome phenotype of chronic lung allograft dysfunction: An exploratory single-center real-world retrospective study.

Belumosudil in patients with bronchiolitis obliterans syndrome phenotype of chronic lung allograft dysfunction: An exploratory single-center real-world retrospective study.

Journal: Transplant immunology
Published: May 18, 2026

RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD.

RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD.

Journal: Investigative ophthalmology & visual science
Published: May 14, 2026

Chronic graft-versus-host disease.

Chronic graft-versus-host disease.

Journal: Nature reviews. Disease primers
Published: May 07, 2026

Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time.

Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time.

Journal: Transplantation and cellular therapy
Published: April 29, 2026

Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial.

Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial.

Journal: Haematologica
Published: April 09, 2026

Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.

Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.

Journal: Bone marrow transplantation
Published: March 30, 2026

Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World Study.

Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World Study.

Journal: Hematological oncology
Published: March 23, 2026

Ruxolitinib-associated pulmonary alveolar proteinosis successfully managed by switching to belumosudil in chronic graft-versus-host disease.

Ruxolitinib-associated pulmonary alveolar proteinosis successfully managed by switching to belumosudil in chronic graft-versus-host disease.

Journal: Blood cell therapy
Published: March 18, 2026
Showing 1-12 of 147

Last Updated: 09/26/2026